Update Focus Interpretation：CANMAT/ISBD 2018 Guidelines for the Management of Patients with Bipolar Disorders

doi:10.12114/j.issn.1007-9572.2018.00.408

Abstract

Abstract: With the development of society and the increase of priority given to mental health，the impact on patients caused by bipolar disorders is brought into focus. How to make a correct diagnosis and treatment is a big challenge to every psychiatrist. In this review，key content and changes for the CANMAT/ISBD 2018 guidelines for the management of patients with bipolar disorders are addressed. The main contents include the general highlights of the guidelines，the basis of bipolar disorders management，drug treatment and the role and recommendation of psychosocial intervention，hoping to give a hand to clinicians to better understand the new guidelines.

Key words: Bipolar disorder, Diagnosis, Treatment, Chronic disease management, Depressive episode, Manic episode, Hypomanic episode

摘要： 随着社会的发展和对精神卫生的重视，双相障碍对患者的影响越来越受到社会关注。如何做到正确诊断和合理治疗是每个临床医生所面对的重大难题。本文对《2018版加拿大抑郁和焦虑治疗网络/国际双相障碍学会双相障碍管理指南》重点内容进行分析解读，主要内容包括指南总体亮点、疾病管理基础、药物治疗、心理社会干预的作用和推荐，以期为广大临床工作者提供新的指导方针。

关键词: 双相情感障碍, 诊断, 治疗, 慢病管理, 抑郁发作, 躁狂发作, 轻躁狂发作

CHEN Jun,FANG Yiru,XU Yifeng. Update Focus Interpretation：CANMAT/ISBD 2018 Guidelines for the Management of Patients with Bipolar Disorders　[J]. Chinese General Practice, 2019, 22(2): 123-127. DOI: 10.12114/j.issn.1007-9572.2018.00.408.
陈俊,方贻儒,徐一峰. 《2018版加拿大抑郁和焦虑治疗网络/国际双相障碍学会双相障碍管理指南》的更新重点解读[J]. 中国全科医学, 2019, 22(2): 123-127. DOI: 10.12114/j.issn.1007-9572.2018.00.408.

References

［1］YATHAM L N，KENNEDY S H，O'DONOVAN C，et al．Canadian Network for Mood and Anxiety Treatments（CANMAT）guidelines for the management of patients with bipolar disorder：consensus and controversies［J］．Bipolar Disord，2005，7（Suppl 3）：5-69．DOI：10.1111/j.1399-5618.2005.00219.x.
［2］YATHAM L N，KENNEDY S H，O'DONOVAN C，et al．Canadian Network for Mood and Anxiety Treatments（CANMAT）guidelines for the management of patients with bipolar disorder：update 2007［J］．Bipolar Disord，2006，8（6）：721-739．DOI：10.1111/j.1399-5618.2006.00432.x.
［3］YATHAM L N，KENNEDY S H，SCHAFFER A，et al．Canadian Network for Mood and Anxiety Treatments（CANMAT）and International Society for Bipolar Disorders（ISBD）collaborative update of CANMAT guidelines for the management of patients with bipolar disorder：update 2009［J］．Bipolar Disord，2009，11（3）：225-255．DOI：10.1111/j.1399-5618.2009.00672.x.
［4］YATHAM L N，KENNEDY S H，PARIKH S V，et al．Canadian Network for Mood and Anxiety Treatments（CANMAT）and International Society for Bipolar Disorders（ISBD）collaborative update of CANMAT guidelines for the management of patients with bipolar disorder：update 2013［J］．Bipolar Disord，2013，15（1）：1-44．DOI：10.1111/bdi.12025.
［5］YATHAM L N，KENNEDY S H，PARIKH S V，et al．Canadian Network for Mood and Anxiety Treatments（CANMAT）and International Society for Bipolar Disorders（ISBD）2018 guidelines for the management of patients with bipolar disorder［J］．Bipolar Disord，2018，20（2）：97-170．DOI：10.1111/bdi.12609
［6］American Psychiatric Association，DSM-5 Task Force.Diagnostic and statistical manual of mental disorders：DSM-5?（5th ed.）［M］．Arlington：American Psychiatric Publishing，2013.
［7］FERRARI A J，CHARLSON F J，NORMAN R E，et al．Burden of depressive disorders by country，sex，age，and year：findings from the global burden of disease study 2010［J］．PLoS Med，2013，10（11）：e1001547．DOI：10.1371/journal.pmed.1001547.
［8］MERIKANGAS K R，AKISKAL H S，ANGST J，et al．Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication［J］．Arch Gen Psychiatry，2007，64（5）：543-552．DOI：10.1001/archpsyc.64.5.543.
［9］SCHAFFER A，ISOMETSA E T，TONDO L，et al．Epidemiology，neurobiology and pharmacological interventions related to suicide deaths and suicide attempts in bipolar disorder：part Ⅰ of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder［J］．Aust N Z J Psychiatry，2015，49（9）：785-802．DOI：10.1177/0004867415594427.
［10］MARANGELL L B，BAUER M S，DENNEHY E B，et al．Prospective predictors of suicide and suicide attempts in 1，556 patients with bipolar disorders followed for up to 2 years［J］．Bipolar Disord，2006，8（5 Pt 2）：566-575．DOI：10.1111/j.1399-5618.2006.00369.x.
［11］SMITH K A，CIPRIANI A.Lithium and suicide in mood disorders：updated meta-review of the scientific literature［J］．Bipolar Disord，2017，19（7）：575-586．DOI：10.1111/bdi.12543.
［12］WAGNER E H.Chronic disease management：what will it take to improve care for chronic illness?［J］．Eff Clin Pract，1998，1（1）：2-4.
［13］MICHALAK E E，MURRAY G，Collaborative Research Team to Study Psychosocial Issues in Bipolar Disorder（CREST.BD）．Development of the QoL.BD：a disorder-specific scale to assess quality of life in bipolar disorder［J］．Bipolar Disord，2010，12（7）：727-740．DOI：10.1111/j.1399-5618.2010.00865.x.
［14］DURGAM S，EARLEY W，LU K，et al．Global improvement with cariprazine in the treatment of bipolar Ⅰ disorder and schizophrenia：a pooled post hoc analysis［J］．Int J Clin Pract，2017，71（12）．DOI：10.1111/ijcp.13037.
［15］MORA E，PORTELLA M J，FORCADA I，et al．Persistence of cognitive impairment and its negative impact on psychosocial functioning in lithium-treated，euthymic bipolar patients：a 6-year follow-up study［J］．Psychol Med，2012，43（6）：1-10．DOI：10.1017/S0033291712001948.
［16］KOZICKY J M，TORRES I J，BOND D J，et al．Comparison of neuropsychological effects of adjunctive risperidone or quetiapine in euthymic patients with bipolar Ⅰ disorder［J］．Int Clin Psychopharmacol，2012，27（2）：91-99．DOI：10.1097/YIC.0b013e32834e3bea.
［17］PACCHIAROTTI I，BOND D J，BALDESSARINI R J，et al．The International Society for Bipolar Disorders（ISBD）task force report on antidepressant use in bipolar disorders［J］．Am J Psychiatry，2013，170（11）：1249-1262．DOI：10.1176/appi.ajp.2013.13020185.
［18］MCGIRR A，VOHRINGER P A，GHAEMI S N，et al．Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression：a systematic review and meta-analysis of randomised placebo-controlled trials［J］．Lancet Psychiatry，2016，3（12）：1138-1146．DOI：10.1016/S2215-0366（16）30264-4.
［19］于欣，方贻儒.中国双相障碍防治指南（第二版）［M］．北京：中华医学电子音像出版社，2015.
YU X，FANG Y R.Guidelines for the prevention and treatment of bipolar disorder in China（2nd edition）［M］．Beijing：Chinese Medical Multimedia Press，2015.
［20］REINARES M，SANCHEZ-MORENO J，FOUNTOULAKIS K N.Psychosocial interventions in bipolar disorder：what，for whom，and when［J］．J Affect Disord，2014，156：46-55．DOI：10.1016/j.jad.2013.12.017.
［21］GONZáLEZ ISASI A，ECHEBURúA E，LIMI?ANA J M，et al．Psychoeducation and cognitive-behavioral therapy for patients with refractory bipolar disorder：a 5-year controlled clinical trial［J］．Eur Psychiatry，2014，29（3）：134-141．DOI：10.1016/j.eurpsy.2012.11.002.
［22］MIKLOWITZ D J，OTTO M W，FRANK E，et al．Intensive psychosocial intervention enhances functioning in patients with bipolar depression：results from a 9-month randomized controlled trial［J］．Am J Psychiatry，2007，164（9）：1340-1347．DOI：10.1176/appi.ajp.2007.07020311.
［23］SCOTT J，PAYKEL E，MORRISS R，et al．Cognitive-behavioural therapy for severe and recurrent bipolar disorders：randomised controlled trial［J］．Br J Psychiatry，2006，188：313-320．DOI：10.1192/bjp.188.4.313.
［24］LAM D H，WATKINS E R，HAYWARD P，et al．A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder：outcome of the first year［J］．Arch Gen Psychiatry，2003，60（2）：145-152.
［25］MIKLOWITZ D J，CHUNG B.Family-focused therapy for bipolar disorder：reflections on 30 years of research［J］．Fam Process，2016，55（3）：483-499．DOI：10.1111/famp.12237.

[1]	YAO Yuzhong, MA Xiaojun, SONG Huan, ZHONG Yu. The Management Effect of Diabetes "1358 model" on Community Diabetes Patients Based on "Precision Management Combining General Care and Specialty Care" [J]. Chinese General Practice, 2023, 26(34): 4308-4314.
[2]	WANG Zhe, DONG Zhihao, ZHENG Hao, KONG Wencheng, ZHANG Yukuan, ZHANG Qiuyue, HAN Jing. Construction of Optimized Treatment Plan of Acupuncture for Migraine Based on Entropy Weight-TOPSIS Method [J]. Chinese General Practice, 2023, 26(34): 4336-4342.
[3]	LI Dianjiang, PAN Enchun, SUN Zhongming, WEN Jinbo, WANG Miaomiao, WU Ming, SHEN Chong. The Current Status and Influencing Factors of Clinical Inertia in Type 2 Diabetes Patients in Community [J]. Chinese General Practice, 2023, 26(34): 4296-4301.
[4]	LIN Kai, YAO Mi, CHEN Zhang, JI Xinxin, LIN Runqi, CHEN Yongsong, Sim MOIRA. Conceptual Framework and Responding Approach of Treatment Burden of Type 2 Diabetes: a Video Recording-based Analysis [J]. Chinese General Practice, 2023, 26(34): 4302-4307.
[5]	WANG Jie, LI Shiming, WEI Shifei, WANG Ningli. Importance of the Role of Primary Care in Myopia Prevention and Control Behavioral Intervention among Children [J]. Chinese General Practice, 2023, 26(33): 4213-4217.
[6]	GAO Jing, ZHOU Shangcheng, GAO Sande, ZOU Guanyang, CHEN Yingyao. Health-related Quality of Life and Its Influencing Factors in Patients with Prevention of Disease in Traditionnal Chinese Medicine based on EQ-5D-5L Scale [J]. Chinese General Practice, 2023, 26(32): 4043-4050.
[7]	LU Guangqi, ZHUANG Minghui, ZHU Liguo, GAO Jinghua, WEI Xu, LI Luguang, YU Jie. Interpretation of Best Practices for Minimally Invasive Lumbar Spinal Stenosis Treatment 2.0 (MIST) : Consensus Guidance from the American Society of Pain and Neuroscience (ASPN) in 2022 [J]. Chinese General Practice, 2023, 26(32): 3995-4000.
[8]	LI Qian, ZHANG Yunshu, YAN Baoping, WANG Jian, MA Yanjuan, WANG Yuan, QIN Yingjie, NA Long, REN Zhiyong, SUN Junwei, DENG Huaili, MA Hongjun, QU Xuehui, ZHOU Nan, SI Tianmei. Efficacy and Safety of Risperidone Microspheres for Injection (Ⅱ) in the Treatment of Patients with Acute Schizophrenia [J]. Chinese General Practice, 2023, 26(32): 4007-4012.
[9]	LOU Zheng, LIU Ying, REN Jingjing. Visits for Medically Unspecified Disease in General Internal Medicine Clinics of County General Hospitals [J]. Chinese General Practice, 2023, 26(31): 3945-3950.
[10]	HONG Yuchun, WU Hua, DU Yishan, LI Shuran, SUN Wenmin, YE Mingyu, ZHANG Yongjian, LI Yang. Development of General Practice Diagnostic Terminology and Coding and Empirical Study on Its Application [J]. Chinese General Practice, 2023, 26(31): 3896-3901.
[11]	ZHU Lin, GUO Yankui, GAO Chen, CHEN Xuezhi, WANG Fashuai. Efficacy of Western Medicine, Chinese Patent Medicine and Their Combination on Post-stroke Insomnia: a Network Meta-analysis [J]. Chinese General Practice, 2023, 26(30): 3823-3832.
[12]	LIU Ruifang, XU Fangxing, LIU Tongku, ZHOU Yujie, WU Xiaofan. Evaluation of the Efficacy and Safety of "Crowbar Effect" Technique to Facilitate Balloon Crossing Resistant Chronic Total Occlusions Lesions [J]. Chinese General Practice, 2023, 26(29): 3683-3688.
[13]	JIANG Qiuhui, LI Xuejun. Exercise is Not the Foundation of Weight Loss [J]. Chinese General Practice, 2023, 26(28): 3477-3481.
[14]	GUO Jia, SUN Huajun, CHEN Ying, ZHANG Jiawen, ZHANG Yaxin, MA Ying, DU Yue. Construction of On-site Evaluation Index System for Integration of Medical and Preventive Services for Chronic Diseases in Primary Health Care Institutions [J]. Chinese General Practice, 2023, 26(28): 3489-3495.
[15]	WANG Yudong, MA Xiaojing, WANG Fang. Influence Mechanism of Capitation for Outpatient Services in Basic Medical Insurance on Medical Expenses Based on the Concept of System Dynamics: a Case Study of Outpatient Payment Mode Reform in Shengzhou, Zhejiang Province [J]. Chinese General Practice, 2023, 26(28): 3496-3501.